Doctors In German "Bazaar" For Patients

28 July 1997

Germany's third-stage health service reform has, it is reported,launched a nationwide battle among panel doctors for patients, described in one Bonn report as a "bazaar."

Under the reform, patients can choose to remain with their current doctor or become private patients. This has reportedly unleashed a competition in which the "dear patient" is offered, in writing, a guaranteed percentage discount on treatment. However, the panel doctors' association says this offers choice to the patient but not the doctor, and that any panel doctor falsifying information in communications with patients over the conditions of reimbursement faces both legal discipline and financial penalties.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight